United States · 
What does Lightchain Capital invest in?
Lightchain Capital invests most often at Series A and Series C (100% of the rounds on record), in sectors such as Life Sciences and Oncology.
Lightchain Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A and Series C: 100% of its rounds
What they do
Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- Life SciencesOncology
- Based in
- St. Louis, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first2 appearances
- 2026
1 round
- Jul
- 2019
1 round
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$57Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Atropos Capital Management, LLC
- SEC number
- CRD 319594
What they claim to have backed
From their own portfolio page (on their website)
4 of 7 we have independently watched raise
AiproteinsC4therapeuticsGeneoscopySimpleroseCarevethealthTidal Media GroupWugen
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.